Lower risk Drug recall · FDA · Published October 28, 2021

Apollo Care VANComycin IV Solution Recall: Crystallization Risk

Apollo Care recalls VANComycin 1g in 250mL saline for possible crystallization causing turbidity. This IV medication, compounded for hospitals, may need replacement if cloudy.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0277-2022Drug Apollo Care ›

Lower-risk recall

Crystallization: Product appears to be turbid.

Take action

Contact the company

Recalling firmApollo Care3801 Mojave Ct Ste 101 · Columbia, MO 65202-4042

✎ GovInfoNow plain-language explainer

Apollo Care is recalling a specific IV vancomycin solution that may become cloudy due to crystallization. This could affect the medication's safety and effectiveness if used without checking for turbidity. Read more at govinfonow.com/recall/35579-apollo-care-vancomycin-iv-solution-recall-crystallization-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35579-apollo-care-vancomycin-iv-solution-recall-crystallization-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0277-2022

Cite this page

“Apollo Care VANComycin IV Solution Recall: Crystallization Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35579-apollo-care-vancomycin-iv-solution-recall-crystallization-risk. Based on FDA recall #D-0277-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0277-2022%22&limit=1).

The FDA announced on Oct. 28, 2021, that Apollo Care voluntarily recalled VANcomycin 1g injection bags due to crystallization hazards. The agency issued recall number D-0277-2022 for the Class II product distributed in Missouri.

How to tell if you have it

Brand: Apollo Care
Product: VANcomycin 1g added to 250mL of 0.9% Sodium Chloride (Injection for Intravenous Use Only), 260 mL per bag, Rx Only
NDC: 71170-254-25
Lot #: AC-016402
Expiration: 2/12/2022
Quantity: 225 bags
Distribution: MO

The hazard

The product appears turbid due to crystallization. The recall is classified as Class II.

Context

GovInfoNow's records show Apollo Care has issued three other recalls since Feb. 15, 2018, including a March 7, 2018, recall for Vancomycin IV bags where stability data did not support the expiry date. Other recent recalls of similar products include Apollo Care SEMAGLUTIDE 10mg Vial Recall (July 29, 2026), Apollo Care SEMAGLUTIDE 4.5mg Vial Recall (July 29, 2026), and Apollo Care SEMAGLUTIDE 9mg Vial Recall (July 29, 2026).

How to tell if you have this one

Check for the label: 'VANComycin 1g added to 250mL of 0.9% Sodium Chloride (Injection for Intravenous Use Only), 260 mL per bag, Rx Only'. The product was compounded by Apollo Care in Columbia, MO, with lot number AC-016402 and expiration 2/12/2022.

Brand
Apollo Care
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check for Turbidity
Inspect the solution for cloudiness before use. If cloudy, do not administer.

Where it went and when

Where it was distributed

Distributed in Missouri.

FDA distribution: “MO” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Missouri.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

Oct 28, 2021Firm started the recall
Dec 8, 2021FDA classified it Class II
Dec 15, 2021Published in FDA’s Enforcement Report
Dec 28, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35579-apollo-care-vancomycin-iv-solution-recall-crystallization-risk">Apollo Care VANComycin IV Solution Recall: Crystallization Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0277-2022 (October 28, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0277-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.